Status:
UNKNOWN
Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis
Lead Sponsor:
First People's Hospital of Chenzhou
Conditions:
Intensive Care Unit
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The plasma level of mtDNA in sepsis is affected by continous venovenous hemofiltation（CVVH）
Detailed Description
Continous renal replacement therapy （CRRT）has become routine for patients with chronic renal failure ，AKI，fliud overload as well as oliguria in ICU .In clinical patients ，continous venovenous hemofoil...
Eligibility Criteria
Inclusion
- Adult septic patients undergoing CRRT
Exclusion
- Missing vists
- transplatation
- cancer
- aquired immunodeficiency syndrome
Key Trial Info
Start Date :
August 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04083482
Start Date
August 20 2018
End Date
December 31 2019
Last Update
September 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Hospital of Chenzhou
Chenzhou, Hunan, China, 450003